CAMBRIDGE, Mass., May 24, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often fatal rare diseases, announced today that the company will participate in the Deutsche Bank 38th Annual Health Care Conference in Boston. Marc Beer, Chief Executive Officer of Aegerion, is scheduled to present on Thursday, May 30 th, 2013 at 8:00 a.m. ET.
Aegerion will also participate in the Jefferies 2013 Global Healthcare Conference in New York City. Mr. Beer is scheduled to present on Tuesday, June 4, 2013 at 2:30 p.m. ET.
CONTACT: Aegerion Pharmaceuticals, Inc. Amanda Murphy Manager, Investor Relations 857-242-5024